Abbott gets FDA clearance for over-the-counter continuous glucose monitors [Verge, The]
DexCom, Inc. (DXCM)
Last dexcom, inc. earnings: 4/28 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
dexcom.com/investors
Company Research
Source: Verge, The
The Libre Rio is designed for Type 2 diabetics who don't use insulin, while the Lingo is for people who want to learn more about their metabolism. Share this story Abbott announced today that the US Food and Drug Administration has cleared two new over-the-counter continuous glucose monitors (CGM). The Lingo is designed for health-conscious consumers who want to get greater insight into their metabolism. Meanwhile, the Libre Rio is designed for Type 2 diabetics who don't rely on insulin. CGMs are small wearable sensors that you typically wear for about 14 days at a time. They don't actually measure your blood sugar but instead measure glucose in interstitial fluid — the stuff between your cells — just under the skin. Thus far, they've generally been used for people with Type 1 or Type 2 diabetes who rely on insulin for treatment. However, there's been a growing push among medical device makers and health tech startups to see whether the tech can help non-insulin dependent diabe
Show less
Read more
Impact Snapshot
Event Time:
DXCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXCM alerts
High impacting DexCom, Inc. news events
Weekly update
A roundup of the hottest topics
DXCM
News
- Breakthrough Studies on Automated Insulin Delivery and CGM for Type 2 Diabetes Unveiled at ADA Scientific Sessions [Yahoo! Finance]Yahoo! Finance
- Is Now An Opportune Moment To Examine DexCom, Inc. (NASDAQ:DXCM)? [Yahoo! Finance]Yahoo! Finance
- DexCom's (DXCM) G6 CGM System Combines With AID in Netherlands [Yahoo! Finance]Yahoo! Finance
- DexCom expands AID partnership into the Netherlands Jun. 20, 2024 10:12 AM ET By: Pranav Ghumatkar , SA News Editor [Seeking Alpha]Seeking Alpha
- Dexcom Expands AID Partnership Into The Netherlands [Yahoo! Finance]Yahoo! Finance
DXCM
Earnings
- 4/25/24 - Beat
DXCM
Sec Filings
- 6/20/24 - Form 4
- 6/18/24 - Form 4
- 6/18/24 - Form 144
- DXCM's page on the SEC website